arrow
C

Christy Ralph

saint james's university hospital
H指数:23
被引数:5,131

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment (vol 15, 1500570, 2024)

通过细胞外囊泡介导的微小RNA重编程肿瘤微环境以增强溶瘤病毒疗法 (vol 15, 1500570, 2024)

2025-04-220
OA
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment

通过细胞外囊泡介导的microRNA重新编程肿瘤微环境来增强溶瘤病毒治疗

2024-12-230
OAAI
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
2024-08-010
OA
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial

Capivasertib联合恩扎鲁他胺治疗多西他赛和阿比曲酮治疗转移性去势抵抗性前列腺癌: 随机II期RE-AKT试验的结果

2024-07-011
OAAI
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors
2023-01-2019
OAAI
STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC)
2021-09-011
OA
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche
2021-03-1912
OAAI
Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy
2020-09-015
OAAI
Genomics of lethal prostate cancer at diagnosis and castration resistance
2020-04-01206
PRE
Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre
2020-02-2029
OAAI
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

浆细胞样树突状细胞协调溶瘤柯萨奇病毒A21诱导的固有和适应性抗肿瘤免疫

2019-07-0130
OAAI
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
2018-01-03302
OAAI
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study
2017-07-0119
OAAI